Document is current
Any future updates will be listed below
-
Authors
Maas-Bauer, Kristina https://orcid.org/0000-0003-1788-2807
Stell, Anna-Verena https://orcid.org/0009-0002-5352-4871
Yan, Kai-Li
de Vega, Enrique
Vinnakota, Janaki Manoja
Unger, Susanne
Núñez, Nicolas
Norona, Johana https://orcid.org/0000-0002-6675-322X
Talvard-Balland, Nana
Koßmann, Stefanie
Schwan, Carsten
Miething, Cornelius https://orcid.org/0000-0003-4699-3805
Martens, Uta S.
Shoumariyeh, Khalid
Nestor, Rosa P.
Duquesne, Sandra
Hanke, Kathrin
Rackiewicz, Michal
Hu, Zehan https://orcid.org/0000-0001-6182-4781
El Khawanky, Nadia
Taromi, Sanaz
Andrlova, Hana
Faraidun, Hemin
Walter, Stefanie
Pfeifer, Dietmar
Follo, Marie
Waldschmidt, Johannes
Melchinger, Wolfgang
Rassner, Michael
Wehr, Claudia https://orcid.org/0000-0002-5037-6175
Schmitt-Graeff, Annette
Halbach, Sebastian https://orcid.org/0000-0002-6827-8178
Liao, James https://orcid.org/0000-0001-9679-4252
Häcker, Georg
Brummer, Tilman https://orcid.org/0000-0003-4387-7905
Dengjel, Joern https://orcid.org/0000-0002-9453-4614
Andrieux, Geoffroy https://orcid.org/0000-0002-5389-9481
Grosse, Robert https://orcid.org/0000-0002-3380-5273
Tugues, Sonia
Blazar, Bruce R. https://orcid.org/0000-0002-9608-9841
Becher, Burkhard https://orcid.org/0000-0002-1541-7867
Boerries, Melanie https://orcid.org/0000-0002-3670-0602
Zeiser, Robert https://orcid.org/0000-0001-6565-3393
- License Information
-
More Information
Article History
Received: 18 April 2020
Accepted: 20 December 2023
First Online: 10 January 2024
Competing interests
: B.R.B. receives remuneration as an advisor to BlueRock Therapeutics; research support from Carisma Therapeutics. The other authors have no conflict of interest with this manuscript to disclose. R.Z. received speaker fees from Novartis, Incyte, MNK, VectivBio, and Sanofi.
